Clarity Pharmaceuticals Ltd

ASX:CU6 株式レポート

時価総額：AU$2.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Clarity Pharmaceuticals マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Colin Biggin

最高経営責任者

AU$1.0m

報酬総額

CEO給与比率43.5%
CEO在任期間5yrs
CEOの所有権1.0%
経営陣の平均在職期間5yrs
取締役会の平均在任期間4.8yrs

経営陣の近況

Recent updates

We Think Clarity Pharmaceuticals (ASX:CU6) Can Easily Afford To Drive Business Growth

Sep 23
We Think Clarity Pharmaceuticals (ASX:CU6) Can Easily Afford To Drive Business Growth

Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Jan 03
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow

May 29
We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow

Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Aug 24
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation

Jan 13
Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation

CEO報酬分析

Clarity Pharmaceuticals の収益と比較して、Colin Biggin の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-AU$42m

Mar 31 2024n/an/a

-AU$36m

Dec 31 2023n/an/a

-AU$31m

Sep 30 2023n/an/a

-AU$28m

Jun 30 2023AU$1mAU$444k

-AU$25m

Mar 31 2023n/an/a

-AU$23m

Dec 31 2022n/an/a

-AU$21m

Sep 30 2022n/an/a

-AU$23m

Jun 30 2022AU$811kAU$347k

-AU$24m

Mar 31 2022n/an/a

-AU$21m

Dec 31 2021n/an/a

-AU$19m

Sep 30 2021n/an/a

-AU$15m

Jun 30 2021AU$907kAU$308k

-AU$10m

Mar 31 2021n/an/a

-AU$9m

Dec 31 2020n/an/a

-AU$9m

Sep 30 2020n/an/a

-AU$8m

Jun 30 2020AU$657kAU$303k

-AU$7m

報酬と市場: Colinの 総報酬 ($USD 626.19K ) は、 Australian市場 ($USD 1.41M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Colinの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Colin Biggin

5yrs

在職期間

AU$1,020,674

報酬

Dr. Colin David Biggin, Ph D., has been Managing Director, Chief Executive Officer and Executive Director at Clarity Pharmaceuticals Ltd since October 1, 2019. Dr. Biggin joined Clarity Pharmaceuticals Pty...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Alan Taylor
Executive Chairman10.9yrsAU$1.22m4.62%
A$ 112.1m
Colin Biggin
MD, CEO & Executive Director5yrsAU$1.02m1.03%
A$ 24.9m
David Green
Chief Financial Officer2.5yrsAU$273.61kデータなし
Shaemus Gleason
Executive Vice President of Operationsno dataデータなしデータなし
Matthew Harris
Chief Scientific Officerno dataAU$241.43k1.92%
A$ 46.5m
Lisa Sadetskaya
Director of Corporate Communications.no dataデータなしデータなし
Mary Bennett
Head of Human Resourceno dataデータなしデータなし
Michelle Parker
Chief Clinical Officerno dataデータなし0.17%
A$ 4.1m
Othon Gervasio
Chief Medical Officerno dataデータなしデータなし
Robert Vickery
Company Secretaryno dataAU$268.69kデータなし

5.0yrs

平均在職期間

経験豊富な経営陣: CU6の経営陣は経験豊富で経験豊富です（平均在職期間は5年）。

取締役

名称ポジション在職期間報酬所有権
Alan Taylor
Executive Chairman10.9yrsAU$1.22m4.62%
A$ 112.1m
Colin Biggin
MD, CEO & Executive Director5yrsAU$1.02m1.03%
A$ 24.9m
Christopher Roberts
Non-Executive Director8.6yrsAU$86.88k5.67%
A$ 137.4m
Thomas Ramdahl
Non-Executive Director5.6yrsAU$86.88k0.16%
A$ 4.0m
Jon Stoner
Member of Scientific Advisory Board1.7yrsデータなしデータなし
Neal Shore
Member of Scientific Advisory Board2.4yrsデータなしデータなし
Rosanne Robinson
Lead Independent Director14yrsAU$95.72k0.056%
A$ 1.4m
Jason Lewis
Member of Scientific Advisory Boardno dataデータなしデータなし
Oliver Sartor
Member of Scientific Advisory Board4.6yrsデータなしデータなし
Paul Donnelly
Member of Scientific Advisory Boardno dataデータなしデータなし
Andrei Iagaru
Member of Scientific Advisory Board2.5yrsデータなしデータなし
Louise Emmett
Member of Scientific Advisory Board2.3yrsデータなしデータなし

4.8yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: CU6の 取締役会 は 経験豊富 であると考えられます ( 4.6年の平均在任期間)。